Genetics of emergent suicidality during antidepressive treatment-Data from a naturalistic study on a large sample of inpatients with a major depressive episode

European Neuropsychopharmacology

Volumn 23, Issue 7, 2013, Pages 663-674

  Musil, Richard ^a   Zill, Peter ^a   Seemüller, Florian ^a   Bondy, Brigitta ^a   Meyer, Sebastian ⁱ   Spellmann, Ilja ^a   Bender, Wolfram ^b   Adli, Mazda ^c   Heuser, Isabella ^c   Fisher, Robert ^d   Gaebel, Wolfgang ^e   Maier, Wolfgang ^f   Rietschel, Marcella ^g   Rujescu, Dan ^a,j   Schennach, Rebecca ^a   Möller, Hans Jürgen ^a   Riedel, Michael ^a,h  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM MÜNCHEN OST   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF BONN   (Germany)

^g CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^h Vincent von Paul Hospital   (Germany)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

more..

Author keywords

Clinical pharmacology clinical trials; Depression; Human; Inpatients; Pharmacogenetics pharmacogenomics; Predictor; Suicidal ideation; TPH2 protein; Unipolar bipolar

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FIRST GENERATION ANTIPSYCHOTIC; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; SECOND GENERATION ANTIPSYCHOTIC; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 1; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE REPLICATION; GENETICS; HAPLOTYPE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SUICIDAL IDEATION;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; TRYPTOPHAN HYDROXYLASE;

EID: 84878943733     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.08.009     Document Type: Article

References (51)

1. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 2000, 157:1-45.
2. Anttila S., Viikki M., Huuhka K., Huuhka M., Huhtala H., Rontu R., et al. TPH2 polymorphisms may modify clinical picture in treatment-resistant depression. Neurosci. Lett. 2009, 464:43-46.
3. Bah J., Lindstrom M., Westberg L., Manneras L., Ryding E., Henningsson S., et al. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res. 2008, 162:221-229.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Bauer M., Whybrow P.C., Angst J., Versiani M., Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: acute and continuation treatment of major depressive disorder. World J. Biol. Psychiatry 2002, 3:5-43.
6. Bauer M., Bschor T., Pfennig A., Whybrow P.C., Angst J., Versiani M., et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J. Biol. Psychiatry 2007, 8:67-104.
7. Beasley C.M., Dornseif B.E., Bosomworth J.C., Sayler M.E., Rampey A.H., Heiligenstein J.H., et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br. Med. J. 1991, 303:685-692.
8. Bellivier F., Chaste P., Malafosse A. Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 124B:87-91.
9. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodological) 2011, 57:289-300.
10. Brent D. In search of endophenotypes for suicidal behavior. Am. J. Psychiatry 2009, 166:1087-1089.
11. Brent D., Melhem N., Ferrell R., Emslie G., Wagner K.D., Ryan N., et al. Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am. J. Psychiatry 2010, 167:190-197.
12. Brent D., Melhem N., Turecki G. Pharmacogenomics of suicidal events. Pharmacogenomics 2010, 11:793-807.
13. Cichon S., Winge I., Mattheisen M., Georgi A., Karpushova A., Freudenberg J., et al. Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5'-region are associated with bipolar affective disorder. Hum. Mol. Genet. 2008, 17:87-97.
14. Cording C., Gaebel W., Spengler A. Die neue psychiatrische Basisdokumentation. Eine Empfehlung der DGPPN zur Qualitätssicherung im (teil-) stationären Bereich. [The new psychiatric basic documentation. A recommendation by the DGPPN for quality assurance in inpatient treatment]. Spektrum Psychiatr. Nervenheilkunde 1995, 24:3-41.
15. Courtet P., Jollant F., Buresi C., Castelnau D., Mouthon D., Malafosse A. The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr. Genet. 2005, 15:189-193.
16. Du L., Faludi G., Palkovits M., Bakish D., Hrdina P.D. Serotonergic genes and suicidality. Crisis 2001, 22:54-60.
17. Du L., Faludi G., Palkovits M., Sotonyi P., Bakish D., Hrdina P.D. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002, 13:1195-1198.
18. FDA US Food & Drug Administration, 2007. Antidepressant Use in Children, Adolescents, and Adults. Available from: http://www.fda.gov/cder/drug/antidepressants.
19. Grigoroiu-Serbanescu M., Diaconu C.C., Herms S., Bleotu C., Vollmer J., Muhleisen T.W., et al. Investigation of the tryptophan hydroxylase 2 gene in bipolar I disorder in the Romanian population. Psychiatr. Genet. 2008, 18:240-247.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
21. Harvey M., Gagne B., Labbe M., Barden N. Polymorphisms in the neuronal isoform of tryptophan hydroxylase 2 are associated with bipolar disorder in French Canadian pedigrees. Psychiatr. Genet. 2007, 17:17-22.
22. Hothorn T., Hornik K., Zeileis A. Unbiased recursive partitioning. A Conditional Inference Framework. J. Comput. Graph. Stat. 2006, 15(3):651-674.
23. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol. Clin. Exp. Res. 2005, 29:8-16.
24. Laje G., Allen A.S., Akula N., Manji H., John R.A., McMahon F.J. Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet. Genomics 2009, 19:666-674.
25. Laje G., Paddock S., Manji H., Rush A.J., Wilson A.F., Charney D., et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am. J. Psychiatry 2007, 164:1530-1538.
26. Lin Y.M., Chao S.C., Chen T.M., Lai T.J., Chen J.S., Sun H.S. Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Arch. Gen. Psychiatry 2007, 64:1015-1024.
27. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 1987, 334:1-100.
28. Mann J.J., Arango V.A., Avenevoli S., Brent D.A., Champagne F.A., Clayton P., et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol. Psychiatry 2009, 65:556-563.
29. Menke A., Lucae S., Kloiber S., Horstmann S., Bettecken T., Uhr M., et al. Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation. Am. J. Psychiatry 2008, 165:917-918.
30. Menke A., Domschke K., Czamara D., Klengel T., Hennings J., Lucae S. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmaco. 2012, 37(3):797-807.
31. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
32. *D study. Arch. Gen. Psychiatry 2007, 64:689-697.
33. Perroud N., Aitchison K.J., Uher R., Smith R., Huezo-Diaz P., Marusic A., et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 2009, 34:2517-2528.
34. Perroud N., Courtet P., Vincze I., Jaussent I., Jollant F., Bellivier F., et al. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav. 2008, 7:314-322.
35. Perroud N., Uher R., Ng M.Y., Guipponi M., Hauser J., Henigsberg N. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J 2012, 12(1):68-77.
36. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
37. R Development Core Team, 2011. R: A Language and Environment for Statistical Computing. Vienna, Austria.
38. Roche S., McKeon P. Support for tryptophan hydroxylase-2 as a susceptibility gene for bipolar affective disorder. Psychiatr. Genet. 2009, 19:142-146.
39. Rujescu D., Giegling I., Sato T., Hartmann A.M., Moller H.J. Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis. Biol. Psychiatry 2003, 54:465-473.
40. Sarchiapone M., Carli V., Roy A., Iacoviello L., Cuomo C., Latella M.C., et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008, 57:139-145.
41. Seemuller F., Riedel M., Obermeier M., Bauer M., Adli M., Mundt C., et al. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. Int. J. Neuropsychopharmacol. 2009, 12:181-189.
42. Seemuller F., Severus E., Moller H.J., Riedel M. Antidepressants and suicidality in younger adults-is bipolar illness the missing link?. Acta Psychiatr. Scand. 2009, 119:166.
43. Seemuller F., Moller H.J., Obermeier M., Schennach-Wolff R., Riedel M. Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years. Evid Based Ment. Health 2010, 13:52.
44. Seemuller F., Riedel M., Obermeier M., Bauer M., Adli M., Kronmuller K., et al. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur. Neuropsychopharmacol. 2010, 20:346-355.
45. Wittchen, H.U., Wunderlich, U., Gruschwitz, S., Zaudig, M., 1997. Strukturiertes Klinisches Interview für DSM-IV. Hogrefe, Göttingen.
46. Zalsman G., Patya M., Frisch A., Ofek H., Schapir L., Blum I., et al. Association of polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: a multi-center study. World J. Biol. Psychiatry 2011, 12:33-41.
47. Zarrilli F., Angiolillo A., Castaldo G., Chiariotti L., Keller S., Sacchetti S., et al. Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:599-600.
48. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., Taubman J., et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch. Gen. Psychiatry 2005, 62:1109-1118.
49. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol. Psychiatry 2004, 9:1030-1036.
50. Zill P., Buttner A., Eisenmenger W., Bondy B., Ackenheil M. Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur. Neuropsychopharmacol. 2004, 14:282-284.
51. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry 2004, 56:581-586.